{"id":2102297,"date":"2026-08-19T19:00:48","date_gmt":"2026-08-19T16:00:48","guid":{"rendered":"https:\/\/analyse.optim.biz\/?p=2102297"},"modified":"2026-08-19T19:00:48","modified_gmt":"2026-08-19T16:00:48","slug":"vaccine-breakthrough-stops-cancer-returning-in-trial","status":"publish","type":"post","link":"https:\/\/analyse.optim.biz\/?p=2102297","title":{"rendered":"Vaccine breakthrough stops cancer returning in trial"},"content":{"rendered":"<p>[analyse_image type=&#8221;featured&#8221; src=&#8221;https:\/\/ichef.bbci.co.uk\/news\/1024\/branded_news\/ed5d\/live\/40f76380-9bfa-11f1-bbc9-198f60b94eaf.jpg&#8221;]<\/p>\n<article>\n<div>\n<div data-component=\"image-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 dYcznU\">\n<figure class=\"Grid-styles__GridStyled-sc-70d90311-0 ieGDnl\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 gvGaxq\">\n<div data-testid=\"hero-image\" class=\"Image-styles__ImageCardStyled-sc-8c99a12b-1 jJQpIc\"><img decoding=\"async\" src=\"https:\/\/static.files.bbci.co.uk\/bbcdotcom\/web\/20260817-125657-b933f830d3-web-3.18.0-12\/grey-placeholder.png\" class=\"Image-styles__ImageStyled-sc-8c99a12b-0 kpUtIW hide-when-no-script\" aria-label=\"image unavailable\"><img decoding=\"async\" src=\"https:\/\/ichef.bbci.co.uk\/news\/480\/cpsprodpb\/ed5d\/live\/40f76380-9bfa-11f1-bbc9-198f60b94eaf.jpg.webp\" loading=\"eager\" alt=\"Getty Images Close-up of a healthcare professional administering an injection into a person&apos;s upper arm, with white gloved hands holding a syringe and cotton swab during a vaccination appointment.\" class=\"Image-styles__ImageStyled-sc-8c99a12b-0 cVsHni\"><span class=\"Image-styles__CreditStyled-sc-8c99a12b-2 dVFjVB\">Getty Images<\/span><\/div>\n<\/div>\n<\/figure>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">A new personalised vaccine given in combination with a drug has stopped skin cancer returning in patients during a trial, representing a potentially watershed moment in cancer treatment.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">The vaccine, developed by drug companies Merck &amp; Co or MSD, and Moderna, was given to patients with high-risk melanoma, a type of skin cancer, after they had surgery.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Early results show this new jab extended the length of time these patients were cancer free, but it&#8217;s unclear for how long, according to an announcement by the two firms.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Cancer experts say this is a breakthrough, but emphasise caution as the full results have not been released or peer-reviewed whereby independent experts examine and check the trial findings.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">And even after the trials process has finished, the treatment would still need to be approved by regulators and then go through another approval process before it was made available on the NHS.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">The vaccine, called Intismeran, was given in combination with Keytruda, an immunotherapy drug already used in cancer treatment.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Compared with taking the Keytruda on its own, the companies said taking the drug and vaccine together significantly increased the time patients remained cancer free and reduced the risk of the disease spreading to other organs.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">The phase three trial involved more than 1,000 patients who had high-risk stage two, three or four melanoma &#8211; meaning they ranged from having large tumours in a specific area to cancers which had already spread to other parts of the body.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"subheadline-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 fMCMex\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 tlbDj\">\n<h2 class=\"Headline-styles__HeadlineStyled-sc-6b3bb442-0 knYLIy\">&#8216;Shows promise&#8217;<\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Prof Peter Johnson, National Clinical Director for Cancer at NHS England, told the BBC&#8217;s Today Programme it was an exciting development. <\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">&#8220;Most of the cancer immune treatments we have been using up til now have been about cutting the immune system loose and hoping that it recognises the cancer. This [new treatment] is a way to direct it very specifically.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">&#8220;It feels like it&#8217;s a very important advance for us.&#8221; He said the NHS was preparing to bring this type of treatment to patients. <\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Merck, known as MSD in Europe, and Moderna are calling this a personalised vaccine, meaning it works by targeting an individual patient&#8217;s tumour.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">In order to create this new jab, scientists used mRNA technology &#8211; which was used for some Covid-19 vaccines &#8211; to target specific mutations within the cancer cells by surgically removing a small part of a patient&#8217;s tumour and then sequencing its DNA.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">The result is a personalised anti-cancer jab which is specific to the patient&#8217;s tumour and instructs the immune system to recognise and attack any tumour cells that remain. <\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">The two companies are testing other similar personalised vaccines for lung, bladder and kidney cancers.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Stephane Bancel, chief executive of Moderna, said the findings represent a &#8220;pivotal moment&#8221; in the field of cancer research.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Shares in both Moderna and Merck have surged since the announcement.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Cancer experts have also hailed the news as positive, but are keen to stress the findings are still early.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Dr Talisia Quallo, head of prevention and early detection at Cancer Research UK, said the research &#8220;shows promise&#8221; but said that the interim data still needs to be fully reviewed.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">&#8220;It&#8217;s vital that research like this continues to be funded so that more people with cancer can have personalised treatment options to help them live longer, better lives&#8221;, she added.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Dr Lennard Lee, a consultant medical oncologist, and associate professor at the University of Oxford, said: &#8220;This is certainly good news for patients with melanoma, but the study has much wider implications. It provides proof of principle that personalised cancer vaccines work.&#8221;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">More detailed findings from the study will be presented at a medical conference in October. <\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"image-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 kugUwP\">\n<figure class=\"Grid-styles__GridStyled-sc-70d90311-0 ieGDnl\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 tlbDj\">\n<div data-testid=\"image\" class=\"Image-styles__ImageCardStyled-sc-8c99a12b-1 bOmCce\"><img decoding=\"async\" src=\"https:\/\/static.files.bbci.co.uk\/bbcdotcom\/web\/20260817-125657-b933f830d3-web-3.18.0-12\/grey-placeholder.png\" class=\"Image-styles__ImageStyled-sc-8c99a12b-0 kpUtIW hide-when-no-script\" aria-label=\"image unavailable\"><img decoding=\"async\" src=\"https:\/\/ichef.bbci.co.uk\/news\/480\/cpsprodpb\/4a08\/live\/9d204fd0-9c60-11f1-a291-b542ee92de7c.png.webp\" loading=\"lazy\" alt=\"A thin, grey banner promoting the News Daily newsletter. On the right, there is a graphic of an orange sphere with two concentric crescent shapes around it in a red-orange gradient, like a sound wave. The banner reads: \u201cThe latest news in your inbox first thing.\u201d\n\" class=\"Image-styles__ImageStyled-sc-8c99a12b-0 cVsHni\"><\/div>\n<\/div>\n<\/figure>\n<\/div>\n<\/div>\n<div>\n<div data-component=\"text-block\" class=\"Container-styles__ContainerStyled-sc-8b855a6c-0 cPmzSx\">\n<div class=\"Grid-styles__GridStyled-sc-70d90311-0 hRsXiV\">\n<div class=\"GridItem-styles__GridItemStyled-sc-6cc20e4a-0 bnCeGm\">\n<p class=\"Paragraph-styles__ParagraphStyled-sc-ffb5f5ba-0 fqhmpl\">Get our flagship newsletter with all the headlines you need to start the day. Sign up here.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<p>[analyse_source url=&#8221;https:\/\/www.bbc.com\/news\/articles\/c79gpv7v190o&#8221;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[analyse_image type=&#8221;featured&#8221; src=&#8221;https:\/\/ichef.bbci.co.uk\/news\/1024\/branded_news\/ed5d\/live\/40f76380-9bfa-11f1-bbc9-198f60b94eaf.jpg&#8221;] Getty Images A new personalised vaccine given in combination with a drug has stopped skin cancer returning in patients during a trial, representing a potentially watershed moment in cancer treatment. The vaccine, developed by drug companies Merck &amp; Co or MSD, and Moderna, was given to patients with high-risk melanoma, a type [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[35,226],"class_list":["post-2102297","post","type-post","status-publish","format-standard","hentry","category-politics","tag-bbc-com","tag-crawlmanager"],"_links":{"self":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/2102297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2102297"}],"version-history":[{"count":0,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/2102297\/revisions"}],"wp:attachment":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2102297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2102297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2102297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}